Fig. 3From: Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysisSubgroup meta-analysis of the association between antidiabetic treatments and MACE stratified by drug classes in patients with normal or mild and impaired kidney functionBack to article page